[
  {
    "symbol": "IRTC",
    "price": 100.87,
    "beta": 1.394014,
    "volAvg": 372858,
    "mktCap": 3073589596,
    "lastDiv": 0,
    "range": "85.74-164.69",
    "changes": 4.31,
    "companyName": "iRhythm Technologies, Inc.",
    "currency": "USD",
    "cik": "0001388658",
    "isin": "US4500561067",
    "cusip": "450056106",
    "exchange": "NASDAQ Global Select",
    "exchangeShortName": "NASDAQ",
    "industry": "Medical Devices",
    "website": "https://www.irhythmtech.com",
    "description": "iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.",
    "ceo": "Mr. Quentin S. Blackford",
    "sector": "Healthcare",
    "country": "US",
    "fullTimeEmployees": "1793",
    "phone": "415 632 5700",
    "address": "699 8th Street",
    "city": "San Francisco",
    "state": "CA",
    "zip": "94103",
    "dcfDiff": 5.27916,
    "dcf": 105.589,
    "image": "https://financialmodelingprep.com/image-stock/IRTC.png",
    "ipoDate": "2016-10-20",
    "defaultImage": false,
    "isEtf": false,
    "isActivelyTrading": true,
    "isAdr": false,
    "isFund": false
  }
]